Redefining Innovation
Embracing the 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry
Seiten
2021
Productivity Press (Verlag)
978-1-032-17870-7 (ISBN)
Productivity Press (Verlag)
978-1-032-17870-7 (ISBN)
The 80-80 Rule sets the standard for redefining innovation as a platform to reignite the growth engines of the biopharmaceutical industry, which should become the new normal.
Most people marvel at the level of innovation demonstrated by the biopharmaceutical industry in bringing new products to the market – especially in the past 20 years. However, there is a crisis looming in the industry that should be a concern to all of us who take for granted the constant pace at which new treatments, and increasingly cures, have emerged from the laboratories of current sector incumbents. In the book, we examine the evolution of the biopharmaceutical industry to understand how it became what we term a "unicorn industry" with a unique, US-centered business model that has led to multiple blockbuster products (aka, unicorns) year after year. We explore how past success has created perceived barriers to innovation diversification beyond the chemical or biological-based biopharmaceutical product, and highlight the warning signs of the industry’s decline. We define a potential pathway for transforming the industry’s business model by broadening the definition, sources, and enablers of innovation beyond the traditional biopharmaceutical product. We introduce and advocate for the 80-80 Rule - "Being 80% confident that you will only be 80% right the first time should feel normal." The 80-80 Rule is a theme that emphasizes speed and willingness to embrace uncertainty and overcome internal barriers to change. It sets the standard for redefining innovation as a platform to reignite growth of the biopharmaceutical industry.
Most people marvel at the level of innovation demonstrated by the biopharmaceutical industry in bringing new products to the market – especially in the past 20 years. However, there is a crisis looming in the industry that should be a concern to all of us who take for granted the constant pace at which new treatments, and increasingly cures, have emerged from the laboratories of current sector incumbents. In the book, we examine the evolution of the biopharmaceutical industry to understand how it became what we term a "unicorn industry" with a unique, US-centered business model that has led to multiple blockbuster products (aka, unicorns) year after year. We explore how past success has created perceived barriers to innovation diversification beyond the chemical or biological-based biopharmaceutical product, and highlight the warning signs of the industry’s decline. We define a potential pathway for transforming the industry’s business model by broadening the definition, sources, and enablers of innovation beyond the traditional biopharmaceutical product. We introduce and advocate for the 80-80 Rule - "Being 80% confident that you will only be 80% right the first time should feel normal." The 80-80 Rule is a theme that emphasizes speed and willingness to embrace uncertainty and overcome internal barriers to change. It sets the standard for redefining innovation as a platform to reignite growth of the biopharmaceutical industry.
Ruchin Kansal, Jeff Huth
Reviews
Setting the Context
Foreword
Preface
Acknowledgments
The 80-80 Rule
Section I REDEFINING INNOVATION
1 Rise of a Unicorn Industry
2 The Unicorn Industry Loses Its Wings
3 An Experiment in Challenging the Status Quo
4 Innovation Redefined
5 Next-Generation Unicorn Industry
Section II IGNITING GROWTH
6 Applying "The 80-80 Rule"
7 Setting Up for Success
8 Finding White Spaces
9 Developing New Ventures
10 Becoming Adept at Partnering
11 Afterword
Index
| Erscheinungsdatum | 01.10.2021 |
|---|---|
| Zusatzinfo | 20 Illustrations, black and white |
| Verlagsort | London |
| Sprache | englisch |
| Maße | 156 x 234 mm |
| Gewicht | 385 g |
| Themenwelt | Medizin / Pharmazie ► Pharmazie |
| Technik | |
| Wirtschaft ► Betriebswirtschaft / Management ► Unternehmensführung / Management | |
| ISBN-10 | 1-032-17870-1 / 1032178701 |
| ISBN-13 | 978-1-032-17870-7 / 9781032178707 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
wie man Menschen wirklich weiterbringt
Buch | Softcover (2024)
Vahlen (Verlag)
CHF 37,65
wie Teams funktionieren und wann sie effektiv arbeiten
Buch | Softcover (2024)
Vahlen (Verlag)
CHF 45,95
Buch | Softcover (2023)
Springer Gabler (Verlag)
CHF 46,15
